Global /Norway /Healthcare /Medical Devices /MEDI
chevron_leftBack

Medistim ASA

MEDI
OSL: MEDI Delayed
162.50NOK 0.3%
15.43 USD
As of 24 April 2025, Medistim ASA has a market cap of $284.11M USD, ranking #15419 globally and #87 in Norway. It ranks #1517 in the Healthcare sector, and #178 in the Medical Devices industry.
Global Rank
15419
Country Rank
87
Sector Rank
1517
Industry Rank
178
Key Stats
Market Cap
$284.11MUSD
2.96B NOK
Enterprise Value
$266.91MUSD
2.81B NOK
Revenue (TTM)
$53.45MUSD
556.16M NOK
EBITDA (TTM)
$13.94MUSD
146.8M NOK
Net Income (TTM)
$9.98MUSD
103.83M NOK
EBITDA Margin
26%
Profit Margin
19%
PE Ratio
28.6
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Kari Krogstad open_in_new
Employees
154
Founded
1984
Website
medistim.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0.3% -0.6% -14% 8.9% -8.4% -9.7%

Markets

Exchange Ticker Price
Euronext Oslo Børs
MIC: XOSL
PRIMARY
MEDI
ISIN: NO0010159684
Shares Out.:
18.314M1 Shares Float: 15.936M2
TV:
SA:
YF:
GF:
BA:
MS:
162.50 NOK
London Stock Exchange
MIC: XLON
0OCD
ISIN: NO0010159684
TV:
SA:
YF:
GF:
BA:
MS:
160.50 NOK
Nasdaq Stockholm
MIC: XSTO
MEDIO
Medistim ASA
ISIN: NO0010159684
TV:
SA:
YF:
GF:
BA:
MS:
161.00 NOK
Frankfurt Stock Exchange
MIC: XFRA
MD1
Medistim ASA
ISIN: NO0010159684
TV:
SA:
YF:
GF:
BA:
MD1
MS:
13.55 EUR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Medistim ASA

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplant surgery; and imaging probes for intraoperative use. It also provides QuickFit TTFM probes, which is designed to hold the vessel and ensure precise measurements on various types of vessel grafts; Vascular TTFM probes for locking slide mechanism designed to secure the vessel while minimizing the manipulation; ultrasound imaging probes; and Doppler probes that are used to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, the company distributes and sells third party medical equipment. Medistim ASA was founded in 1984 and is headquartered in Oslo, Norway.

Similar Companies

Industry: Medical Devices (Norway)
Name
Market Cap diff.
Gentian Diagnostics ASA
GENT
$72.18M
751.07M NOK
-75%
Lifecare AS
LIFE
$14.29M
148.69M NOK
-95%
Observe Medical ASA
OBSRV
$1.55M
16.18M NOK
-99%
Industry: Medical Devices (Global)
Name
Market Cap diff.
Abbott Laboratories
ABT
$225.18B
79K%
Boston Scientific Corp.
BSX
$146.31B
51K%
Stryker Corp.
SYK
$136.3B
48K%
Medtronic plc
MDT
$107.41B
38K%
Siemens Healthineers AG
SHL
$58.0B
50.97B EUR
20K%